期刊文献+
共找到3篇文章
< 1 >
每页显示 20 50 100
18β-甘草次酸介导MRPL35/RRM2信号抑制非小细胞肺癌恶性进展
1
作者 曹旭 杨瑞 +1 位作者 方婉婷 李云慧 《解剖科学进展》 2025年第2期205-208,共4页
目的探究18β-甘草次酸处理对非小细胞肺癌细胞增殖、凋亡、迁移和侵袭的影响及可能机制。方法不同剂量18β-甘草次酸处理H1299细胞后,CCK-8方法和克隆形成实验检测细胞增殖能力,流式细胞术检测细胞凋亡情况,Transwell实验检测细胞迁移... 目的探究18β-甘草次酸处理对非小细胞肺癌细胞增殖、凋亡、迁移和侵袭的影响及可能机制。方法不同剂量18β-甘草次酸处理H1299细胞后,CCK-8方法和克隆形成实验检测细胞增殖能力,流式细胞术检测细胞凋亡情况,Transwell实验检测细胞迁移和侵袭能力,Western blot检测各组细胞中MRPL35、RRM2和β-catenin蛋白的表达。结果18β-甘草次酸能降低H1299细胞增殖活性、克隆形成能力、迁移和侵袭能力,并诱导细胞凋亡,降低细胞中MRPL35、RRM2和β-catenin的表达。过表达MRPL35部分逆转18β-甘草次酸处理对H1299细胞中RRM2和β-catenin表达的下调作用。结论18β-甘草次酸介导MRPL35/RRM2信号抑制非小细胞肺癌细胞增殖、迁移和侵袭并诱导细胞凋亡。 展开更多
关键词 18Β-甘草次酸 非小细胞肺癌 mrpl35 RRM2
原文传递
Depletion of MRPL35 inhibits gastric carcinoma cell proliferation by regulating downstream signaling proteins 被引量:2
2
作者 Ling Yuan Jia-Xin Li +6 位作者 Yi Yang Yan Chen Ting-Ting Ma Shuang Liang Yang Bu Lei Yu Yi Nan 《World Journal of Gastroenterology》 SCIE CAS 2021年第16期1785-1804,共20页
BACKGROUND Gastric carcinoma(GC)is a digestive system disease with high morbidity and mortality.However,early clinical detection is difficult,and the therapeutic effect for advanced disease is not satisfactory.Thus,fi... BACKGROUND Gastric carcinoma(GC)is a digestive system disease with high morbidity and mortality.However,early clinical detection is difficult,and the therapeutic effect for advanced disease is not satisfactory.Thus,finding new tumor markers and therapeutic targets conducive to the treatment of GC is imperative.MRPL35 is a member of the large subunit family of mitochondrial ribosomal protein.MRPL35 shows the characteristic of oncogene in colorectal cancer and esophageal cancer,which promotes the exploration of the correlation between MRPL35 and GC.We proposed that the expression of MRPL35 might be critical in GC.AIM To study the effect of MRPL35 knockdown on GC cell proliferation.METHODS The expression of MRPL35 in GC was evaluated based on data from the publictumor database UALCAN(www.ualcan.path.uab.edu).The effect of theexpression of MRPL35 on the prognosis was evaluated with KMplot(www.kmplot.com).The expression of MRPL35 was assessed on the tissuemicroarray by immunohistochemistry and the level of MRPL35 mRNA in 25 pairsof clinical GC tissues and matched adjacent tissues was detected by quantitativereverse transcription-polymerase chain reaction.Celigo cell count assay,colonyformation assay,and flow cytometry were used to assess the role of MRPL35 inGC cell proliferation and apoptosis in vitro.Additionally,tumor formationexperiment in BALB/c nude mice was utilized to determine the effect of MRPL35on GC cell proliferation.After knockdown of MRPL35,related proteins wereidentified by isobaric tags for relative and absolute quantification analysis,andthe expression of related proteins was detected by Western blot.RESULTSThe expression of MRPL35 was up-regulated in GC(P=1.77×10^(-4)).The Kaplan-Meier plots of the overall survival indicated that high expression of MRPL35 wasassociated with a poor survival in GC.Compared with adjacent tissues,theexpression of MRPL35 in GC tissues was increased,which was related to age(P=0.03),lymph node metastasis(P=0.007),and pathological tumor-node-metastasisstage(P=0.024).Knockdown of MRPL35 inhibited GC cell proliferation andcolony formation and induced apoptosis.Animal experiment results showed thatknockdown of MRPL35 inhibited tumor formation in BALB/c nude mice.Westernblotting analysis showed that after knockdown of MRPL35,the expression ofPICK1 and BCL-XL proteins decreased,and that of AGR2 protein increased.CONCLUSIONCollectively,our findings demonstrate that knockdown of MRPL35 inhibits GCcell proliferation through related proteins including PICK1,BCL-XL,and AGR2. 展开更多
关键词 Gastric carcinoma mrpl35 Apoptosis PROLIFERATION Tissue microarray Isobaric tags for relative and absolute quantification
暂未订购
非小细胞肺癌组织中MRPL35、RasGRF2表达及其与患者临床病理特征及预后的关系
3
作者 邢祥 朱晓丽 +2 位作者 吉光磊 谷兰海 张翰林 《医学理论与实践》 2024年第14期2447-2450,共4页
目的:探讨非小细胞肺癌(NSCLC)组织中线粒体核糖体大亚基蛋白35(MRPL35)、Ras蛋白鸟苷酸释放因子2(RasGRF2)表达及其与患者临床病理特征及预后的关系。方法:选取2018年1月—2020年11月我院收治的186例NSCLC患者,所有患者均行手术治疗,... 目的:探讨非小细胞肺癌(NSCLC)组织中线粒体核糖体大亚基蛋白35(MRPL35)、Ras蛋白鸟苷酸释放因子2(RasGRF2)表达及其与患者临床病理特征及预后的关系。方法:选取2018年1月—2020年11月我院收治的186例NSCLC患者,所有患者均行手术治疗,分别于术中留取癌组织标本、癌旁组织标本。探讨NSCLC组织中MRPL35、RasGRF2表达及其与患者临床病理特征及预后的关系。结果:与癌旁组相比,NSCLC组RasGRF2阳性表达率更低,MRPL35阳性表达率更高(P<0.05)。MRPL35、RasGRF2阴性表达与NSCLC患者分化程度、TNM分期、淋巴结转移情况有关(P<0.05)。RasGRF2阳性患者3年生存率显著高于RasGRF2阴性患者,MRPL35阳性患者3年生存率显著低于MRPL35阴性患者(P<0.05)。NSCLC患者预后不良的危险因素包括低分化程度、TNM分期Ⅲ~Ⅳ期、MRPL35阳性、淋巴结转移、RasGRF2阴性(P<0.05)。结论:NSCLC患者癌组织中RasGRF2呈低表达,MRPL35呈高表达,且两者与低分化程度、TNM分期Ⅲ~Ⅳ期、淋巴结转移相关,也是NSCLC患者预后不良的危险因素,有望作为辅助评估NSCLC患者预后的潜在生物标志物。 展开更多
关键词 非小细胞肺癌 mrpl35 RasGRF2 病理特征 预后
暂未订购
上一页 1 下一页 到第
使用帮助 返回顶部